Home » Stocks » Lannett Company

Lannett Company, Inc. (LCI)

Stock Price: $6.26 USD 0.06 (0.97%)
Updated Aug 5, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 252.60M
Revenue (ttm) 541.67M
Net Income (ttm) -31.25M
Shares Out 40.35M
EPS (ttm) -0.81
PE Ratio n/a
Forward PE 4.76
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 5, 2020
Last Price $6.26
Previous Close $6.20
Change ($) 0.06
Change (%) 0.97%
Day's Open 6.28
Day's Range 6.10 - 6.35
Day's Volume 320,676
52-Week Range 4.89 - 15.52

More Stats

Market Cap 252.60M
Enterprise Value 856.99M
Earnings Date (est) Sep 1, 2020
Ex-Dividend Date n/a
Shares Outstanding 40.35M
Float 30.26M
EPS (basic) -0.81
EPS (diluted) -0.81
FCF / Share 0.92
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield 14.11%
Payout Ratio n/a
Shares Short 9.71M
Short Ratio 14.44
Short % of Float 36.09%
Beta 1.86
PE Ratio n/a
Forward PE 4.76
P/FCF Ratio 7.09
PS Ratio 0.47
PB Ratio 0.77
Revenue 541.67M
Operating Income 33.49M
Net Income -31.25M
Free Cash Flow 35.63M
Net Cash -604.40M
Net Cash / Share -14.98
Gross Margin 50.92%
Operating Margin 6.18%
Profit Margin -5.80%
FCF Margin 6.58%
ROA 3.09%
ROE -9.62%
ROIC 2.90%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

(55.75% upside)
Current: $6.26
Target: 9.75
*Average 12-month price target from 4 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth-4.26%8.09%16.75%33.34%48.6%81.24%22.82%15.12%-14.65%-
Gross Profit24428930128630615457.4238.9523.3241.34
Operating Income-26214586.4513122688.0918.766.91-1.1812.71
Net Income-27228.69-0.5844.7815057.1013.323.95-0.287.82
Shares Outstanding37.7837.1336.8136.4435.8333.6628.4728.2626.7624.74
Earnings Per Share-7.200.75-
EPS Growth----70.3%149.38%252.17%228.57%---
Operating Cash Flow17611916513512945.1026.5011.12-6.206.94
Capital Expenditures-9.89-52.29-48.58-24.25-31.58-26.03-7.51-5.23-7.25-11.32
Free Cash Flow16666.2411711196.9419.0718.995.89-13.45-4.38
Cash & Equivalents14098.5914523921414651.1529.2324.6622.50
Total Debt7298399041,0621.011.146.517.167.827.72
Net Cash / Debt-589-741-759-82321314544.6422.0716.8414.78
Book Value33459956155446329412911110688.96
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Lannett Company, Inc.
Country United States
Employees 1,020
CEO Timothy C. Crew

Stock Information

Ticker Symbol LCI
Stock Exchange New York Stock Exchange
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Unique Identifier NYSE: LCI


Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nasal, patch, foam, buccal, sublingual, suspensions, soft gel, injectable, and oral dosages. It also provides its products for various medical indications, such as antibiotic, anti-psychosis, cardiovascular, central nervous system, gallstone, gastrointestinal, glaucoma, migraine, muscle relaxant, pain management, respiratory, thyroid deficiency, urinary, and others medical indications. The company's primary products include Levothyroxine Sodium tablets, Fluphenazine tablets, Verapamil SR tablets, Ursodiol capsules, Methylphenidate CD capsules, Omeprazole capsules, Pantoprazole Sodium DR tablets, Sumatriptan Nasal spray, Dicyclomine tablets and capsules, Metolazone tablets, and Methylphenidate Hydrochloride ER, as well as cocaine hydrochloride solution. It sells its pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical companies, managed care organizations, hospital buying groups, governmental entities, and health maintenance organizations. The company has supply and development agreements with Summit Bioscience LLC, HEC Pharm Group, Andor Pharmaceuticals LLC, Dexcel Pharma, Elite Pharmaceuticals, RivoPharm, and various other companies. Lannett Company, Inc. was founded in 1942 and is headquartered in Philadelphia, Pennsylvania.